vs
Side-by-side financial comparison of Organon & Co. (OGN) and UPBOUND GROUP, INC. (UPBD). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.3× UPBOUND GROUP, INC.). UPBOUND GROUP, INC. runs the higher net margin — 1.7% vs -13.6%, a 15.3% gap on every dollar of revenue. On growth, UPBOUND GROUP, INC. posted the faster year-over-year revenue change (10.9% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $24.0M). Over the past eight quarters, UPBOUND GROUP, INC.'s revenue compounded faster (4.5% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Upbound Group, Inc. is a leading US provider of flexible lease-to-own solutions for consumer goods. It offers furniture, consumer electronics, home appliances, and accessories, catering to customers seeking accessible payment alternatives to traditional retail financing.
OGN vs UPBD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.2B |
| Net Profit | $-205.0M | $19.7M |
| Gross Margin | 49.2% | 49.0% |
| Operating Margin | -9.8% | 4.8% |
| Net Margin | -13.6% | 1.7% |
| Revenue YoY | -5.3% | 10.9% |
| Net Profit YoY | -288.1% | -36.3% |
| EPS (diluted) | $-0.78 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
| Q4 25 | $-205.0M | $19.7M | ||
| Q3 25 | $160.0M | $13.2M | ||
| Q2 25 | $145.0M | $15.5M | ||
| Q1 25 | $87.0M | $24.8M | ||
| Q4 24 | $109.0M | $31.0M | ||
| Q3 24 | $359.0M | $30.9M | ||
| Q2 24 | $195.0M | $33.9M | ||
| Q1 24 | $201.0M | $27.7M |
| Q4 25 | 49.2% | 49.0% | ||
| Q3 25 | 53.5% | 48.3% | ||
| Q2 25 | 54.8% | 49.4% | ||
| Q1 25 | 55.6% | 46.8% | ||
| Q4 24 | 56.3% | 47.1% | ||
| Q3 24 | 58.3% | 47.8% | ||
| Q2 24 | 58.4% | 49.4% | ||
| Q1 24 | 59.0% | 48.3% |
| Q4 25 | -9.8% | 4.8% | ||
| Q3 25 | 15.2% | 4.5% | ||
| Q2 25 | 14.4% | 4.4% | ||
| Q1 25 | 6.7% | 5.3% | ||
| Q4 24 | 8.1% | 7.3% | ||
| Q3 24 | 13.1% | 6.6% | ||
| Q2 24 | 14.6% | 7.5% | ||
| Q1 24 | 14.5% | 5.6% |
| Q4 25 | -13.6% | 1.7% | ||
| Q3 25 | 10.0% | 1.1% | ||
| Q2 25 | 9.1% | 1.3% | ||
| Q1 25 | 5.8% | 2.1% | ||
| Q4 24 | 6.8% | 2.9% | ||
| Q3 24 | 22.7% | 2.9% | ||
| Q2 24 | 12.1% | 3.2% | ||
| Q1 24 | 12.4% | 2.5% |
| Q4 25 | $-0.78 | $0.35 | ||
| Q3 25 | $0.61 | $0.22 | ||
| Q2 25 | $0.56 | $0.26 | ||
| Q1 25 | $0.33 | $0.42 | ||
| Q4 24 | $0.42 | $0.55 | ||
| Q3 24 | $1.38 | $0.55 | ||
| Q2 24 | $0.75 | $0.61 | ||
| Q1 24 | $0.78 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $120.5M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $695.7M |
| Total Assets | $12.9B | $3.3B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $120.5M | ||
| Q3 25 | $672.0M | $107.0M | ||
| Q2 25 | $599.0M | $106.8M | ||
| Q1 25 | $547.0M | $107.3M | ||
| Q4 24 | $675.0M | $60.9M | ||
| Q3 24 | $763.0M | $85.1M | ||
| Q2 24 | $704.0M | $82.5M | ||
| Q1 24 | $575.0M | $84.8M |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $695.7M | ||
| Q3 25 | $906.0M | $687.3M | ||
| Q2 25 | $733.0M | $685.5M | ||
| Q1 25 | $542.0M | $679.2M | ||
| Q4 24 | $472.0M | $629.0M | ||
| Q3 24 | $493.0M | $611.8M | ||
| Q2 24 | $144.0M | $596.3M | ||
| Q1 24 | $48.0M | $578.3M |
| Q4 25 | $12.9B | $3.3B | ||
| Q3 25 | $13.6B | $3.2B | ||
| Q2 25 | $13.5B | $3.1B | ||
| Q1 25 | $13.2B | $3.0B | ||
| Q4 24 | $13.1B | $2.6B | ||
| Q3 24 | $12.8B | $2.6B | ||
| Q2 24 | $12.2B | $2.6B | ||
| Q1 24 | $11.9B | $2.6B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $41.6M |
| Free Cash FlowOCF − Capex | $96.0M | $24.0M |
| FCF MarginFCF / Revenue | 6.4% | 2.0% |
| Capex IntensityCapex / Revenue | 3.0% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 2.11× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $238.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $41.6M | ||
| Q3 25 | $264.0M | $118.4M | ||
| Q2 25 | $220.0M | $7.8M | ||
| Q1 25 | $75.0M | $137.7M | ||
| Q4 24 | $390.0M | $-61.9M | ||
| Q3 24 | $141.0M | $106.2M | ||
| Q2 24 | $332.0M | $15.0M | ||
| Q1 24 | $76.0M | $45.4M |
| Q4 25 | $96.0M | $24.0M | ||
| Q3 25 | $218.0M | $97.9M | ||
| Q2 25 | $181.0M | $-10.4M | ||
| Q1 25 | $43.0M | $127.2M | ||
| Q4 24 | $335.0M | $-74.0M | ||
| Q3 24 | $99.0M | $88.3M | ||
| Q2 24 | $300.0M | $613.0K | ||
| Q1 24 | $30.0M | $33.6M |
| Q4 25 | 6.4% | 2.0% | ||
| Q3 25 | 13.6% | 8.4% | ||
| Q2 25 | 11.4% | -0.9% | ||
| Q1 25 | 2.8% | 10.8% | ||
| Q4 24 | 21.0% | -6.9% | ||
| Q3 24 | 6.3% | 8.3% | ||
| Q2 24 | 18.7% | 0.1% | ||
| Q1 24 | 1.8% | 3.1% |
| Q4 25 | 3.0% | 1.5% | ||
| Q3 25 | 2.9% | 1.8% | ||
| Q2 25 | 2.4% | 1.6% | ||
| Q1 25 | 2.1% | 0.9% | ||
| Q4 24 | 3.5% | 1.1% | ||
| Q3 24 | 2.7% | 1.7% | ||
| Q2 24 | 2.0% | 1.3% | ||
| Q1 24 | 2.8% | 1.1% |
| Q4 25 | — | 2.11× | ||
| Q3 25 | 1.65× | 8.96× | ||
| Q2 25 | 1.52× | 0.50× | ||
| Q1 25 | 0.86× | 5.56× | ||
| Q4 24 | 3.58× | -2.00× | ||
| Q3 24 | 0.39× | 3.44× | ||
| Q2 24 | 1.70× | 0.44× | ||
| Q1 24 | 0.38× | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
